Ticker AMRX – Amneal Pharma A – sales, description, marketcap – Tickerday.com

AMRX

Amneal Pharma A

Index: NYSE; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 1.15B; Volume: 131.58K; AvgVol 3m: 1.10M; Beta: 1.33;

Cost estimate:

P/E: ; EPS: -1.56; EPS growth quarter/prev quarter: 38.40%;

EPS growth this year: 68.60%; EPS growth past 5 years: -40.00%;

EPS ttm: -1.56;

P/S: 0.70; P/B: 1.99; P/Cashflow: 4.60; P/FCF: 4.32;

Sales: 1.74B; Sales growth quarter/prev quarter: 14.90%; Sales growth past 5 years: 22.20%;

Profitability:

Gross Margin: 32.50%; Profit Margin: -11.20%; Operating Margin: 7.30%;

ROA – return on assets: -4.90%; ROE – return on equity: -72.30%; LT Debt/Equity: 9.36; Total Debt/Equity: 9.46;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 1.10%; Insider Transactions:1.05%;

Institutional Ownership: 69.90%; Institutional Transactions: 1.75%;

Data update: 07/10/2020.

Leave a comment

Your email address will not be published. Required fields are marked *